Co-segregation of MEN2 and Hirschsprung's disease: the same mutation of RET with both gain and loss-of-function?
- PMID: 10220148
- DOI: 10.1002/(SICI)1098-1004(1999)13:4<331::AID-HUMU11>3.0.CO;2-#
Co-segregation of MEN2 and Hirschsprung's disease: the same mutation of RET with both gain and loss-of-function?
Abstract
Multiple endocrine neoplasia type 2 (MEN2) and Hirschsprung's disease (HSCR) are two dominantly inherited neurocristopathies ascribed to mutations in the RET gene [Chakravarti, 1996; Pasini et al., 1996; Eng and Mulligan, 1997]. MEN2 is a cancer syndrome comprising three related clinical subtypes: (1) MEN type 2A (MEN2A; MIM# 171400) characterized by the association of medullary thyroid carcinoma (MTC), pheochromocytoma (Pheo), and hyperparathyroidism; (2) MEN type 2B (MEN2B; MIM# 162300), which includes MTC, Pheo, mucosal neuromas, ganglioneuromatosis of the digestive tract, and skeletal abnormalities; and (3) familial MTC (FMTC; MIM# 155240), defined by the sole occurrence of MTC. HSCR (MIM# 142623) is a congenital malformation caused by the absence of enteric plexuses in the hindgut, leading to bowel obstruction in neonates. The RET gene (MIM# 164761) codes for a transmembrane tyrosine kinase, a component of a multimeric complex that also comprises one of four members of a novel family of glycosylphosphatidylinositol (GPI)-anchored receptor, GFRalpha((1-4) (e.g., GFRA1, MIM# 601496; references are detailed in Baloh et al. [1998]. Four structurally related soluble factors-glial cell line-derived neurotrophic factor (GDNF), neurturin, persephin, and artemin-are the ligands of these multimolecular receptors in which the nature of the GFRalpha determines the ligand specificity of the complex [see Baloh et al., 1998, for references]. It is well documented that RET/GFRalpha-1/GDNF delivers a signal critical for the survival of the early neural crest-derived precursors that colonize the intestine below the rostral foregut and give rise to the enteric nervous plexuses [Gershon, 1997; Cacalano et al., 1998; Enomoto et al., 1998].
Similar articles
-
Glial cell line-derived neurotrophic factor differentially stimulates ret mutants associated with the multiple endocrine neoplasia type 2 syndromes and Hirschsprung's disease.Endocrinology. 1998 Aug;139(8):3613-9. doi: 10.1210/endo.139.8.6124. Endocrinology. 1998. PMID: 9681515
-
Mutation analysis of glial cell line-derived neurotrophic factor, a ligand for an RET/coreceptor complex, in multiple endocrine neoplasia type 2 and sporadic neuroendocrine tumors.J Clin Endocrinol Metab. 1997 Sep;82(9):3025-8. doi: 10.1210/jcem.82.9.4197. J Clin Endocrinol Metab. 1997. PMID: 9284737
-
Mechanisms of development of multiple endocrine neoplasia type 2 and Hirschsprung's disease by ret mutations.Recent Results Cancer Res. 1998;154:229-36. doi: 10.1007/978-3-642-46870-4_14. Recent Results Cancer Res. 1998. PMID: 10027003 Review.
-
Human glial cell line-derived neurotrophic factor receptor alpha 4 is the receptor for persephin and is predominantly expressed in normal and malignant thyroid medullary cells.J Biol Chem. 2001 Mar 23;276(12):9344-51. doi: 10.1074/jbc.M008279200. Epub 2000 Dec 14. J Biol Chem. 2001. PMID: 11116144
-
[From gene to disease; from the RET gene to multiple endocrine neoplasia types 2A and 2B, sporadic and familial medullary thyroid carcinoma, Hirschsprung disease and papillary thyroid carcinoma].Ned Tijdschr Geneeskd. 2001 Nov 17;145(46):2217-21. Ned Tijdschr Geneeskd. 2001. PMID: 11757244 Review. Dutch.
Cited by
-
RET overactivation leads to concurrent Hirschsprung disease and intestinal ganglioneuromas.Development. 2020 Nov 5;147(21):dev190900. doi: 10.1242/dev.190900. Development. 2020. PMID: 32994173 Free PMC article.
-
The soluble ectodomain of RetC634Y inhibits both the wild-type and the constitutively active Ret.Biochem J. 2003 Jun 15;372(Pt 3):897-903. doi: 10.1042/BJ20021530. Biochem J. 2003. PMID: 12630912 Free PMC article.
-
Renal aplasia in humans is associated with RET mutations.Am J Hum Genet. 2008 Feb;82(2):344-51. doi: 10.1016/j.ajhg.2007.10.008. Epub 2008 Jan 31. Am J Hum Genet. 2008. PMID: 18252215 Free PMC article.
-
Multiple endocrine neoplasia type 2 and RET: from neoplasia to neurogenesis.J Med Genet. 2000 Nov;37(11):817-27. doi: 10.1136/jmg.37.11.817. J Med Genet. 2000. PMID: 11073534 Free PMC article. Review.
-
RET signaling in endocrine tumors: delving deeper into molecular mechanisms.Endocr Pathol. 2007 Summer;18(2):57-67. doi: 10.1007/s12022-007-0009-5. Endocr Pathol. 2007. PMID: 17916994 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources